CHI's Innovative Tissue-Based Diagnostics

Innovative Tissue-Based Diagnostics is designed to feature recent breakthroughs in the field of pathology such as testing for predictive cancer biomarkers, decoding cancer molecular profiles, next generation sequencing, circulating tumor cells, etc. The goal of the conference is to enhance knowledge and experience exchange among industry and research pathologists as well as other researchers working with human tissue. This meeting will highlight the new generation of tissue-based diagnostic technologies aimed primarily towards molecular diagnostics of cancer. In addition, a session dedicated to the fascinating field of in vivo pathology will be offered.

KEY TAKE AWAYS:

• Learn about pathology's contribution and role in cancer drug development
• Get updates on how cancer pathology helps create genetically informed cancer medicine
• Learn how next generation sequencing has revolutionized genomics and is now on the verge of being widely adopted for medical sequencing
• Hear insights into in vivo microscopy and intra-operative optical imaging – a fascinating new and rapidly developing field of diagnostic medicine
• Get instructed on the challenges and solutions in assay development for the clinical setting

SESSIONS: 

• Pathology in Cancer Drug Development
• Molecular Pathology as the Driving Force for Personalized Oncology
• Bridging Radiology-Pathology Divide

PRE-CONFERENCE SHORT COURSE (June 4)

• Next-Generation Sequencing as a Diagnostics Platform

View conference agenda, short course agenda and register at: http://www.healthtech.com/tdx

or call 781-972-5400.